Stay updated with breaking news from Peter Deyoung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugmakers are reducing their reliance on Chinese contractors and turning to manufacturers in India for clinical trials and early-stage manufacturing, as tensions with China and concerns over supply chain exposure increase.
Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, a move that is benefiting rivals in India, according to...
Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, a move that is benefiting rivals in India, according to interviews with 10 industry executives and experts. China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there. That is leading some biotech companies to consider using manufacturers in India to produce active pharmaceutical ingredient (API) for clinical trials or ot...
Pharmaceutical companies are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, industry insiders said.
India is seeking a bigger foothold in pharmaceutical services sector